This editorial presents the Research Topic on innovative AI approaches for quantitative MRI, emphasizing how AI can help overcome practical barriers that still limit the clinical use of qMRI, including long acquisition times, limited sequence availability, artifacts, inter-site variability, and complex post-processing. The article summarizes four contributions covering retrospective T2 mapping from conventional MRI, pharmacokinetics-informed DCE-MRI analysis, automated 4D-flow vessel segmentation, and MRF signal synthesis from conventional brain MRI. Together, these studies show how AI can support biomarker estimation, automate labor-intensive processing steps, and extract quantitative information from standard clinical imaging. The main conclusion is that AI may make qMRI more accessible and reproducible, but its adoption requires rigorous validation based on quantitative endpoints, external generalizability, clinical relevance, and, where possible, uncertainty or quality-control mechanisms.

Editorial: Innovative AI approaches in quantitative MRI: from image enhancement to biomarker estimation

Mastropietro A.
Primo
;
Scalco E.;
2026

Abstract

This editorial presents the Research Topic on innovative AI approaches for quantitative MRI, emphasizing how AI can help overcome practical barriers that still limit the clinical use of qMRI, including long acquisition times, limited sequence availability, artifacts, inter-site variability, and complex post-processing. The article summarizes four contributions covering retrospective T2 mapping from conventional MRI, pharmacokinetics-informed DCE-MRI analysis, automated 4D-flow vessel segmentation, and MRF signal synthesis from conventional brain MRI. Together, these studies show how AI can support biomarker estimation, automate labor-intensive processing steps, and extract quantitative information from standard clinical imaging. The main conclusion is that AI may make qMRI more accessible and reproducible, but its adoption requires rigorous validation based on quantitative endpoints, external generalizability, clinical relevance, and, where possible, uncertainty or quality-control mechanisms.
2026
Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato - STIIMA (ex ITIA)
Istituto di Tecnologie Biomediche - ITB
artificial intelligence—AI
biomarker estimation
image processing
magnetic resonance imaging
quantitative MRI (qMRI)
File in questo prodotto:
File Dimensione Formato  
fradi-6-1796451-1.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 134.66 kB
Formato Adobe PDF
134.66 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/585601
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact